Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: PuddleGlum who wrote (191)	12/4/2000 1:14:54 AM
From: tuck	Respond to of 1784

PuddleGlum, Thanks for your kind words. One company I turned up a while ago is Argonaut. None of the chemists have spoken of them with regard to equipping their dreamlabs. It is definitely trickle and it's a pretty pure play. It had a solid third quarter, in line with expectations: siliconinvestor.com It is suffering from lock-up issues and looks cheap here. ipolockup.com End of lock-up shorting sometimes often starts a month ahead. Keeping CRL in mind for that, too, as it comes out 12/20. Indeed short interest, though not huge, has jumped sharply. The stock is trading at almost 50% of its IPO. biz.yahoo.com If we get a bad day in the next couple of days -- a reasonable chance -- Trickle will nibble a couple hundred shares at 8. Cheers, Tuck